申请人:UNIVERSITY OF FLORIDA
公开号:EP0221588A2
公开(公告)日:1987-05-13
The invention provides compounds adapted for the site-specific/sustained delivery of a centrally acting drug species to the brain having the formula [D-DHC] and the non-toxic pharmaceutically acceptable salts thereof, wherein [D] is a centrally acting drug species which is an antiviral agent, an antiinflammatory steroid, a narcotic or an estrogen and which contains at least two reactive hydroxyl functional groups, and [DHC] is the reduced, biooxidizable, blood-brain barrier penetrating lipoidal form of a dihydropyridine=pyridinium salt redox carrier comprising at least one dihydropyridine ring system of the formula
wherein R is lower alkyl or benzyl and the dotted line indicates the presence of a double bond in either the 2 or 3 position of the dihydropyridine ring, a ring carbon atom of each dihydropyridine ring system being connected via a bridging group to a reactive hydroxyl functional group in the centrally acting drug species. The corresponding quaternary derivatives are also described.
本发明提供了适用于向大脑定点/持续递送中枢作用药物的化合物,其具有式[D-DHC]及其无毒的药学上可接受的盐,其中[D]是中枢作用药物,它是一种抗病毒剂、一种抗炎类固醇、一种麻醉剂或一种雌激素,并含有至少两个活性羟基官能团,而[DHC]是还原的、可生物氧化的、可透过血脑屏障的脂质形式的二氢吡咯、DHC]是二氢吡啶=吡啶鎓盐氧化还原载体的还原型、可生物氧化、可穿透血脑屏障的类脂形式,该载体包含至少一个式中的二氢吡啶环系统。
其中 R 为低级烷基或苄基,虚线表示在二氢吡啶环的 2 位或 3 位存在双键,每个二氢吡啶环系统的环碳原子通过桥基与中心作用药物种类中的活性羟基官能团相连。还描述了相应的季衍生物。